Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The effects of estrogen on human hair growth are unclear and need more research.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Low estrogen compared to androgen may cause female hair loss.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Estrogen deficiency, like after menopause or certain surgeries, leads to faster skin aging and health issues.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.